KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Gross Margin (2016 - 2026)

Boston Scientific's Gross Margin history spans 18 years, with the latest figure at 69.46% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 62.0% to 69.46% in Q1 2026 year-over-year; TTM through Mar 2026 was 69.17%, a 51.0% increase, with the full-year FY2025 number at 69.01%, up 41.0% from a year prior.
  • Gross Margin hit 69.46% in Q1 2026 for Boston Scientific, roughly flat from 69.6% in the prior quarter.
  • Over the last five years, Gross Margin for BSX hit a ceiling of 70.63% in Q2 2023 and a floor of 67.65% in Q2 2025.
  • Historically, Gross Margin has averaged 69.01% across 5 years, with a median of 68.85% in 2022.
  • Biggest five-year swings in Gross Margin: soared 180bps in 2023 and later crashed -152bps in 2025.
  • Tracing BSX's Gross Margin over 5 years: stood at 68.85% in 2022, then rose by 1bps to 69.23% in 2023, then dropped by -2bps to 67.86% in 2024, then rose by 3bps to 69.6% in 2025, then fell by 0bps to 69.46% in 2026.
  • Business Quant data shows Gross Margin for BSX at 69.46% in Q1 2026, 69.6% in Q4 2025, and 69.93% in Q3 2025.